Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Neurofibroma”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableStudy completedNCT02777775
What this trial is testing

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

Who this might be right for
Cutaneous NeurofibromasNeurofibromatosis Type 1Plexiform Neurofibromas
Corewell Health West 71
Testing effectiveness (Phase 2)Study completedNCT04435665
What this trial is testing

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
NFlection Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Testing effectiveness (Phase 2)Looking for participantsNCT06159166
What this trial is testing

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Who this might be right for
NF1Cutaneous NeurofibromaMonotherapy
Johns Hopkins University 24
Not applicableActive Not RecruitingNCT05581511
What this trial is testing

Natural History Study of Cutaneous Neurofibromas in People With NF1

Who this might be right for
Neurofibromatosis Type 1Neurofibromatosis 1Neurofibromatosis (Nonmalignant)+1 more
Johns Hopkins University 500
Testing effectiveness (Phase 2)Study completedNCT05005845
What this trial is testing

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis 1
NFlection Therapeutics, Inc. 199
Early research (Phase 1)Study completedNCT00865644
What this trial is testing

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)Study completedNCT03090971
What this trial is testing

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
Fundação Educacional Serra dos Órgãos 7
Early research (Phase 1)Looking for participantsNCT07102394
What this trial is testing

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Who this might be right for
NF1NeurofibromatosisCutaneous Neurofibroma+3 more
Johns Hopkins University 10
Not applicableStudy completedNCT04941027
What this trial is testing

Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Stanford University 1,046
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Early research (Phase 1)Looking for participantsNCT06961565
What this trial is testing

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Who this might be right for
NF1 MutationNeurofibroma PlexiformNeurofibroma, Plexiform+2 more
Pasithea Therapeutics Corp. 56
Not applicableTemporarily pausedNCT06934928
What this trial is testing

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Who this might be right for
Neurofibromatosis 1 (NF1)Neurofibromatosis Type I
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT05438290
What this trial is testing

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Who this might be right for
Cutaneous Neurofibroma
Nicholas Gulati 17
Early research (Phase 1)Study completedNCT01682811
What this trial is testing

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Who this might be right for
Neurofibromatoses
Harry T Whelan, MD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05521048
What this trial is testing

Doxycycline in Cutaneous Schwannoma (NF2)

Who this might be right for
Neurofibromatosis Type 2
Massachusetts Eye and Ear Infirmary 19
Testing effectiveness (Phase 2)Looking for participantsNCT02728388
What this trial is testing

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Who this might be right for
NEUROFIBROMATOSIS 1
Donald Basel 30
Not applicableUnknownNCT03893643
What this trial is testing

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Who this might be right for
Neurofibromatosis 2Dermatology/Skin - Other
Centre Hospitalier Universitaire de Nice 1,000
Load More Results